Quality statement 11: Optimal radiotherapy

Quality statement

People with lung cancer stage I–III who are offered radiotherapy with curative intent receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Quality measure

Structure: Evidence of local arrangements and written clinical protocols to ensure that people with lung cancer stage I–III who are offered radiotherapy with curative intent receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Process:

a) Proportion of people with lung cancer stage I–III who receive radiotherapy with curative intent.

Numerator – the number of people in the denominator who receive radiotherapy with curative intent.

Denominator – the number of people with lung cancer stage I–III.

b) Proportion of people with lung cancer receiving radiotherapy with curative intent who receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Numerator – the number of people in the denominator who receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Denominator – the number of people with lung cancer receiving radiotherapy with curative intent.

What the quality statement means for each audience

Service providers ensure there are systems in place for people with lung cancer stage I–III who are offered radiotherapy with curative intent to receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Healthcare professionals ensure people with lung cancer stage I–III who are offered radiotherapy with curative intent receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Commissioners ensure they commission services for people with lung cancer I–III who are offered radiotherapy with curative intent to receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

People with early or locally spread (stage I–III) lung cancer who are offered radiotherapy to try and cure the cancer receive treatment techniques that focus the radiation on the tumour while keeping damage to the healthy tissue to a minimum.

Source guidance

Lung cancer: diagnosis and management (2019) NICE guideline NG122, recommendations 1.4.25–1.4.29

Data source

Structure: Local data collection.

Process:

a) The Health and Social Care Information Centre National Lung Cancer Data Audit collects data on the proportion of patients submitted to the audit receiving radiotherapy.

b) Data fields necessary for the extraction of data on radiotherapy dose, fractionation and scheduling are available in the National Cancer Intelligence Network National Radiotherapy Dataset.

Definitions

Examples of optimising radiotherapy techniques include 4‑D radiotherapy planning and treatment, image‑guided radiotherapy, intensity‑modulated radiotherapy and stereotactic body radiotherapy.